Evaluation of inhaler technique and patient satisfaction with fixed-combination budesonide/formoterol dry-powder inhaler in chronic obstructive pulmonary disease (COPD): data on real-life clinical practice in Turkey
| Autor: | Mustafa Ilgaz Doğrul, Savas Yasar, Özgür Batum, Can Öztürk, Osman Altiparmak, Gonca Can, Belgin Ikidag, Oznur Uzunay, Muzaffer Onur Turan, Nezaket Erdogan, Tuncer Senol, Mustafa Demirel, Akin Kaya, Serife Torun, Murat Cirit, Şeyma Başlılar, Mehmethan Turan, Murat Cam, Semih Ağanoğlu, Cahit Bilgin, Leyla Yucesoy, Bengü Şaylan, Arif Kelesoglu, Cahit Demir, Kevser Melek |
|---|---|
| Předmět: |
Male
Pulmonary and Respiratory Medicine Budesonide medicine.medical_specialty Turkey Critical Care and Intensive Care Medicine Pulmonary Disease Chronic Obstructive Patient satisfaction Formoterol Fumarate Internal medicine Administration Inhalation Humans Medicine Outpatient clinic Aged COPD business.industry Inhaler Age Factors Dry Powder Inhalers Middle Aged medicine.disease Dry-powder inhaler Bronchodilator Agents Drug Combinations Cross-Sectional Studies Treatment Outcome Budesonide/formoterol Ethanolamines Patient Satisfaction Educational Status Surgery Formoterol Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | Europe PubMed Central |
| Popis: | INTRODUCTION The present study was designed to evaluate inhaler techniques and patient satisfaction with fixed-combination budesonide/formoterol dry-powder inhaler chronic obstructive pulmonary disease (COPD) in Turkey in real-life clinical practice. PATIENTS AND METHODS A total of 442 patients with COPD [mean (SD) age: 63.2 (10.6) years, 76.5% were males] were included in this cross-sectional study conducted at 25 outpatient clinics across Turkey. Data on socio-demographic characteristics, characteristics of COPD, inhaler technique and satisfaction with dry-powder inhaler were recorded at a single crosssectional visit performed at the study enrolment. RESULTS Patients were characterized by prominence of moderate to severe (78.1%) COPD, high rate of regular use of overall COPD medications (89.4%) and Turbuhaler® for an average of 33.7 months, predominance of males (76.5%), primary education (85.7%), urban location (68.3), ex-smokers (61.1%) and spending time outdoors for ≥ 4 hour/day (62.0%). Use of correct techniques was evident in majority of patients (≥ 94%), whereas inhalation maneuvers including breathing out gently away from mouthpiece without blowing into it (71.9%) and holding the breath for 5-10 seconds (78.3%) were performed correctly by lesser percent of patients especially in the older group (≥ 65 years, p< 0.05). Overall percent of patients with the feeling that she/he used the inhaler very/fairly correctly was 73.3%, while 86% of patients identified that they were very/fairly satisfied with the inhaler, irrespective of age and educational status. CONCLUSION In conclusion, our findings revealed the majority of patients are able to use Turbuhaler® correctly regardless of the educational status, while older age was associated with higher rate of errors in inhalation maneuvers in the real clinical practice in Turkey. Majority of our patients identified Turbuhaler® to be very/fairly convenient regarding ease of use, portability, and usability with an overall self-confidence in using the inhaler correctly among 73% and the satisfaction rate of 86%; irrespective of age and educational level. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|